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Wiskott-Aldrich Syndrome Protein-Deficient Mice
Reveal a Role for WASP
in T but Not B Cell Activation
Lymphocytes from WAS patients have an altered cy-
toskeleton with a reduction in cell surface microvilli as
well as defects in antigen receptor±induced signaling
(reviewed by Remold-O'Donnell et al., 1996). Linkage
studies were employed to map the WAS gene to Xp11.22
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of the knowledge of WASP structure and mutations, theThe Wiskott-Aldrich syndrome (WAS) is a human X-linked
overall mechanism by which lack of WASP expressionimmunodeficiency resulting from mutations in a gene
leads to the complex WAS phenotype remains unknown.(WASP) encoding a cytoplasmic protein implicated in
Studies of blood cells from human WAS patients haveregulating the actin cytoskeleton. To elucidate WASP
provided insights into potential functions of the WASfunction,we disruptedthe WASP gene in mice by gene-
protein. T cell lines derived from WAS patients havetargeted mutation.WASP-deficientmiceshowed appar-
defective responses to antigen receptor±induced stimu-ently normal lymphocyte development, normal serum
lation in vitro. However, both calcium mobilization uponimmunoglobulin levels, and the capacity to respond to
antigen receptor±induced stimulation and proliferativeboth T-dependent and T-indepedent type II antigens.
responses to compounds such as phorbol esters (phor-However, these mice did have decreased peripheral
bol myristate acetate or PMA) and calcium ionophoresblood lymphocyte and platelet numbers and devel-
(ionomycin), which bypass receptor-proximal signalingoped chronic colitis. Moreover, purified WASP-defi-
events, appear to be normal in these cells (Molina etcient T cells showed markedly impaired proliferation
al., 1993). Together, these results suggested a role forand antigen receptor cap formation in response to
WASP in T cell signal transduction downstream fromanti-CD3e stimulation. Yet, purified WASP-deficient B
the T cell receptor (TCR) but upstream from PMA andcells showed normal responses to anti-Ig stimulation.
ionomycin targets (e.g., protein kinase C and Ca21 mobi-We discuss the implications of our findings regarding
lization, respectively). Additional studies showed thatWASP function in receptor signaling and cytoskeletal
T lymphocytes from WAS patients contained reducedreorganization in T and B cells and compare the effects
numbers and size of surface microvilli, consistent withof WASP deficiency in mice and humans.
a role for WASP in regulation of the actin cytoskeleton
(Kenney et al., 1986; Molina et al.,1992). A direct connec-Introduction
tion between the aberrant TCR signaling and altered
cytoskeleton in T cell lines from WAS patients cameThe Wiskott-Aldrich syndrome (WAS) is characterized
from the finding that such cells formed abnormal shapesby severe immunodeficiency, thrombocytopenia, ec-
upon antigen receptor±induced activation and failed tozema, and lymphoreticular malignancies. Untreated pa-
polymerize actin (Gallego et al.,1997). On the otherhand,tients die in the first decade of life (Rosen et al., 1995).
the role of WASP in B cell receptor signaling has not
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signaling in WAS-deficient human B cells (Simon et al.,11 Present address: Department of Microbiology and Immunology,
Vanderbilt University Medical School, Nashville, TN 37232. 1992; Henriquez et al., 1994).
Immunity
82
Figure 1. Targeted Disruption of the WASP Gene by Homologous Recombination
(A) Targeting strategy. Endogenous WASP locus (upper bar), targeting construct (middle bar), and targeted WASP locus (lower bar) are
displayed. The first 11 (of 12) coding exons are shown by small black rectangles, with selected restriction sites denoted above bars. The
neomycin-resistance (neo) and thymidine kinase (tk) genes used for positive and negative selection, respectively, are indicated. Probe used
for screening ES transfectants is indicated with small filled rectangle under upper bar. Scale bar 5 700 bp.
(B) Southern blot analysis of tail DNA isolated from male hemizygous WASP1/ (1), WASP2/ (2) and female heterozygous WASP1/2 (1/2) mice.
Using probe noted in targeting schematic, upon XbaI digestion a neo gene insertion by homologous recombination into the WASP locus
results in the shift of a single 5.5 kb band (arrow) to a 7.5 kb band (arrowhead).
(C) Western blot analysis of protein extracts of thymocytes (THY), B cells (B), and T cells (T) from wild-type (1) and WASP2//RAG22/2 chimeric
(2) mice. WASP runs at approximately 65 kDa (arrow) and is absent in lysates from lymphoid tissues isolated from WASP2//RAG22/2 chimeric
mice. Fresh extracts from lymphoid tissues were fractionated by 8% SDS-PAGE. Equal protein loading on immunoblots was confirmed by
Ponceau S staining. The immunoblot was stained using an immunoaffinity-purified rabbit anti-WASP antisera raised against a peptide from
the C terminus of WASP. Identical results were obtained with an antibody raised against the N terminus (data not shown; Kolluri et al., 1996).
(D) Northern Blot analysis of RNA isolated from B and T cells from wild-type (1) and WASP2/ (2) mice probed with a WASP cDNA (upper
panel) or GAPDH control cDNA (lower panel) fragment. The murine WASP cDNA probe contained exons 1±6.
A significant clue to potential WASP functions came role in coordinating responses to external stimuli and
initiating cytoskeletal changes by inducing actin reorga-from the finding that WASP interacts in vivo, via the GBD
domain, with CDC42 (Aspenstrom et al., 1996; Kolluri et nization directly or by acting as an adapter or scaffold
for other signaling and structural molecules.al., 1996; Symons et al., 1996). CDC42 and other Rho
family GTPases (Rac and Rho) are known to regulate A clearer understanding of the functions of WASP
will require elucidation of the signaling and cytoskeletalthe cytoskeleton (reviewed by Hall, 1998). In this context,
CDC42 can directly induce the formation of filopodia events that rely on its function. To gain further insight
into the function of WASP, we have disrupted the WASPand can indirectly induce the formation of lamellipodia
and actin stress fibers through activation of Rac and Rho gene in murine embryonic stem cells, introduced this
mutation into the murine germline, and then examined(Nobes and Hall, 1995). When overexpressed, WASP
induces actin clustering and can prevent such CDC42- the effects of the mutation in WASP-deficient mice.
mediated cytoskeletal changes (Symons et al., 1996).
In this regard, recent studies also have implicated a Results
mammalian WASP homolog (N-WASP) and a yeast
WASP-like protein (Bee1) in regulating the actin cyto- Generation of Mice
The WASP gene is X-linked and, therefore, is presentskeleton (Miki et al., 1996; Li, 1997; Miki et al., 1998). In
addition, several other molecules have been identified, in only a single copy in the male TC-1 ES cell line (re-
ferred to as WASP1/). To disrupt the murine WASP gene,including WIP (WASP-interacting protein) and the coiled-
coil PSTPIP, that can both interact with WASP and regu- we employed gene-targeted mutational techniques to
insert a neomycin-resistance gene (neo) into exon 7 oflate the actin cytoskeleton (Ramesh et al., 1997; Wu et
al., 1998). WASP family proteins may, therefore, play a WASP in the reverse transcriptional orientation in TC-1
Signaling Defects in WASP-Deficient Mice
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Figure 2. Normal Lymphoid Development in Wild-Type and WASP2/ Mice
(A±F) FACS analyses of lymphocytes from wild-type (1) and WASP2/ (2) mice. Two-color flow cytometric analyses was performed onthymocytes
(A), spleen (B±C), and bone marrow (D±E). Percentages of representative lymphoid populations are noted. The histogram (F) demonstrates
the surface CD3e expression on splenic T lymphocytes. The results shown are representative of at least three male mice of each type analyzed
at the age of 6±8 weeks.
cells (Figure 1A). This exon encodes a portion of the were not detectable when RNA from lymphoid tissues of
WASP-deficient mice was assayed by Northern blottingGTPase-binding domain (Aspenstrom et al., 1996; Kol-
luri et al., 1996; Symons et al., 1996). Three independent techniques (Figure 1D). Therefore, we conclude that our
targeted insertion into the WASP gene led to a completeWASP-targeted (WASP2/) ES cell clones were used to
generate chimeric mice, and the offspring were bred to loss of WASP RNA and protein expression.
generate germline WASP2/ male mice (Figure 1B). These
WASP2/ male mice were viable, of similar weight to their Normal Lymphoid Development but Decreased
Peripheral Blood Lymphocyte Numberswild-type littermates, and were fertile. Preliminary analy-
ses of WASP-deficient female mice (WASP2/2) showed in WASP-Deficient Mice
T cell development in the thymus can be followed byno significant differences with the WASP2/ males, indi-
cating that there are no genes on the Y chromosomethat the expression patterns of the CD4 and CD8 surface
antigens. Immature double-negative thymocytes (CD42significantly alter this phenotype. Therefore, although
most of our presented analyses represent studies of CD82) give rise to double-positive thymocytes (CD41
CD81), which are the precursors of single-positive (SP)WASP2/ male mice and lymphocytes, we will simply refer
to all as WASP-deficient mice and lymphocytes. Like- cells (either CD41 CD82 or CD42 CD81), which can mi-
grate to the peripheral organs such as the spleen andwise, we used the RAG2-deficient blastocyst com-
plementation method (Chen et al., 1993) to generate lymph nodes. B lineage cell development can be simi-
larly followed by the presence of B2201/CD432 andWASP2/ lymphocytes from the WASP2/ ES cells; analy-
ses of these lymphocytes in several studies (e.g., devel- B2201/IgM1 pre-B cells in the bone marrow and B2201/
IgM1 mature B cells in the periphery. Flow cytometricopment, proliferation, and capping) revealed no differ-
ences from WASP2/ lymphocytes from the germline analyses of B and T lymphocytes in these various organs
from 6- to 8-week-old WASP-deficient mice revealedmutant mice, indicating that observed defects are likely
intrinsic to the lymphocytes. the presence of normal percentages of the various thy-
mic, T, and B lineage cell populations (Figures 2A±2E;Lymphocyte development occurred relatively nor-
mally in WASP-deficient mice (see below). Therefore, data not shown). Furthermore, the numbers of cells in
thymus, spleen, and lymph nodes (Table 1) were approx-we were able to assess the effects of our targeted muta-
tion on WASP expression by performing Western blot- imately normal in young mutant mice (Table 1). In addi-
tion, we observed relatively normal numbers of B1 cellsting analyses on protein extracts generated from lym-
phoid tissues of WASP-deficient and wild-type control in the peritoneum of WASP-deficient mice (data not
shown). These findings indicate that WASP deficiencymice. WASP was absent from extracts of thymus or from
purified T and B cells from mutant animals, but it was does not have a marked effect on overall lymphocyte
development.readily detectable from those of wild-type animals
(Figure 1C). Furthermore, WASP-hybridizing transcripts In contrast to the normal lymphocyte numbers in the
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Table 1. Peripheral Blood Analysis and Overall Lymphoid Cellularity from Wild-Type (WT) and WASP2/ Mice
Peripheral Blood Lymphoid Organs
Plateletsa Leukocytesa Lymphocytesa Neutrophils Hemoglobin Thymus Spleen Lymph node
Mice (103) (103) (103) (103) (g/dl) (106) (106) (106)
WT 747 6 65 5.9 6 0.95 4.8 6 0.90 0.62 6 0.20 15.2 6 0.36 78 6 14 57 6 18 17 6 9.3
WASP2/ 527 6 38 3.9 6 0.81 2.6 6 0.46 0.80 6 0.20 14.9 6 0.52 89 6 29 41 6 10 12 6 3.1
a Statistically significant difference, p , 0.005 (Student t test).
Data presented are mean values 6 95% confidence interval (CI).
spleen and lymph nodes, the number of lymphocytes in human WAS T cells (Molina et al., 1993) are deficient in
IL-2 secretion. The combination of PMA and ionomycin,the blood of WASP-deficient animals was significantly
reduced compared with wild-type animals (Table 1). This which bypasses cell surface stimulation, led to normal
levels of proliferation in mutant T lymphocytes (Figurelymphopenia was associated with slightly elevated num-
bers of neutrophils but normal numbers of red blood 3A). Therefore, antigen receptor±induced proliferative
responses are defective in WASP-deficient T cells, butcells (Table 1). The decreases in B and T cell numbers
in peripheral blood were comparable (data not shown); CD28 costimulatory pathways and downstream signal-
ing events remain relatively intact.therefore, in the young WASP-deficient mice analyzed
(less than 10 weeks old), there was no significant change To study the role of WASP in antigen receptor±induced
proliferative responses in B cells, we stimulated wild-in blood B to T cell ratios. We conclude that T and
B cell development proceeds in an apparently normal type and WASP-deficient splenic B cells with anti-IgM
antibodies. The antigen receptor±induced proliferativefashion in WASP-deficient mice; however, for as yet
unknown reasons, these animals do have reduced T and responses of wild-type and mutant B cells were indistin-
guishable (Figure 3B). Furthermore, stimulation by lipo-B cell numbers in their peripheral blood.
polysaccharide or anti-CD40 also induced equal prolif-
erative responses inwild-type and mutant B cells (FigureReduced Platelet Numbers in WASP-Deficient Mice
3B). Therefore, in contrast to the result with T cells,WAS patients have platelets that are smaller and mark-
these results indicate that WASP is not required foredly decreased in number (Cooper et al., 1968; Ochs et
antigen receptor±induced proliferative responses in Bal., 1980), often leading to frequent bleeding complica-
cells.tions. Young WASP-deficient mice also had reduced
numbers of platelets compared with wild-type mice (Ta-
ble 1). However, in contrast to findings with WAS-defi-
Defective Antigen Receptor±Induced Cappingcient humans, these differences in platelet numbers,
in WASP-Deficient T Cellsalthough significant, were modest and were not associ-
To investigate potential roles of WASP in regulating theated with reduced platelet size (data not shown) or clini-
T cell cytoskeleton and to further explore potentialcal signs of bleeding.
mechanisms responsible for the defective antigen re-
ceptor±induced proliferation in T cells, we studied theAberrant Antigen Receptor±Induced Proliferation
ability of WASP-deficient T lymphocytes to form capsin WASP-Deficient T Cells, but Not B Cells
upon antigen receptor stimulation. The clustering of sur-To assess whether WASP deficiency results in T cell
face receptors upon receptor cross-linking (ªcappingº;dysfunction, T cells from peripheral lymph nodes of mu-
Taylor et al., 1971) has been demonstrated to requiretant mice were tested for their ability to proliferate in
actin polymerization (de Petris, 1974; Kammer et al.,response to anti-CD3e-mediated antigen receptor stim-
1983). Wild-type and WASP-deficient T cells purifiedulation. WASP-deficient T cells were markedly defective
from lymph nodes were incubated in vitro in the pres-in their ability to proliferate following anti-CD3e stimula-
ence or absence of stimulatory anti-CD3e antibodiestion as compared to wild-type T lymphocytes (Figure
and then surface stained with anti-CD3e antibodies fol-3A). This impairment was not due to decreased CD3e
lowing fixation. Antigen receptor capping was attenu-surface expression, because the level of CD3e expres-
ated by more than 80% in WASP-deficient T cells (Fig-sion on the surface of wild-type and mutant T cells was
ures 4C and 4D) as compared with wild-type T cellssimilar (Figure 2F). Proliferative responses to concana-
(Figures 4A and 4B). Similarly, to assay capping in Bvalin A (Con A), a lectin that stimulates T lymphocytes
cells, we incubated splenic B cells from mutant andby cross-linking surface receptors, were also diminished
wild-type mice with anti-IgM antibodies. In contrast toin WASP-deficient T cells compared to wild-type T cells.
T cells, antigen receptor±induced capping of WASP-However, these latter differences were less pronounced
deficient B cells (Figures 4G and 4H) was identical towhen compared to those mediated via direct antigen
that of wild-type B cells (Figures 4E and 4F). Thesereceptor stimulation (Figure 3A). Notably, costimulation
results parallel the normal antigen receptor±induced Bwith anti-CD28 antibodies or exogenously added IL-2
cell proliferation studies described above and suggestmarkedly improved antigen receptor induced prolifera-
a direct relationship between defective proliferative re-tive responses (Figure 3A); the latter finding is consistent
with the observation that murine (data not shown) and sponses and receptor capping in T cells.
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Figure 3. Defective Antigen Receptor±Induced
Proliferation in WASP-Deficient T Cells, but
Not B Cells
(A) T cell proliferation. Lymph node T cells
from male WASP2/ (empty bars) and age-
matched wild-type (filled bars) mice were cul-
tured in media alone or in the presence of
stimulatory anti-CD3e, anti-CD28, anti-CD3e
plus anti-CD28, or Con A. Each stimulation
was performed in the absence or presence
of exogenous IL-2 as indicated. Signaling
pathways bypassing the surface were as-
sessed by stimulation with phorbol myristate
acetate (PMA) and ionomycin.
(B) B cell proliferation. Splenic B cells from
male WASP2/ (empty bars) and age-matched
wild-type (filled bars) mice were cultured in
media alone or in the presence of stimulatory
anti-IgM (soluble), anti-CD40, or lipopolysac-
charide (LPS). Each stimulation was per-
formed in the presence of exogenous IL-4. In
eachexperiment, cells were cultured in media
for 48 hr, pulsed with 1 mCi [3H]thymidine for
an additional 16 hr, and then collected and
scintillation counted. The data are displayed
as raw cpm values. All assays were con-
ducted in triplicate. Displayed are the results
of one experiment. Each experiment was per-
formed three times yielding similar results.
(Raw cpm values for each of these three ex-
periments are available in table form at http://
www.immunity.com/supplemental/9/1/81).
WASP-Deficient Mice Are Capable of Mounting findings contrast with observations that humans with
WAS have markedly decreased serum IgM and elevatedan Immune Response
Serum levels of immunoglobulin isotypes were deter- IgA levels (Blaese et al., 1968; Cooper et al., 1968; Ochs
et al., 1980) as well as poor antibody responses to carbo-mined by enzyme-linked immunosorbent assay (ELISA)
in 6±8-week-old mutant mice and compared with wild- hydrate and many protein antigens (Blaese et al., 1968;
Cooper et al., 1968; Ochs et al., 1980).type littermates. WASP-deficient mice had normal levels
of all Ig isotypes analyzed (Figure 5). To assess respon-
siveness of WASP-deficient mice to a T-dependent (TD)
antigen, wild-type and mutant mice were immunized Colitis in WASP-Deficient Mice
Unlike human WAS patients, none of the young WASP-with TNP-Ova in incomplete Freund's adjuvant, and
TNP-specific serum antibody titers were measured by deficient mice analyzed developed either hematopoeitic
malignancies or eczema; although this will have to beELISA. The immune responses to this protein antigen
appeared relatively normal with respect to both total further examined in older WASP-deficient mice. How-
ever, the majority of WASP-deficient mice developedimmunoglobulin (Figure 6A) and all tested serum Ig iso-
types (data not shown). To investigate the response chronic colitis by 4 months of age. The most severely
involved colons were diffusely dilated with thickenedto T-independent type II (TI-II) carbohydrate antigens,
wild-type and mutant mice were immunized with TNP- walls and had marked mucosal thickening due to crypt
hyperplasia and the presence of a mixed lymphocyticDextran, and TNP-specific antibody titers were again
determined by ELISA (Figure 6B). Both wild-type and and neutrophilic infiltrate within the lamina propria (Fig-
ure 7). Crypt abscesses were present in colons of ani-WASP-deficient mice responded to this TI-II antigen.
Therefore, serum Ig levels and antibody responses to a mals with severe colitis (Figure 7B). In contrast to wild-
type mice, large numbers of CD41 T cells were scatteredTD and a TI-II antigen in WASP-deficient mice appeared
normal under these immunization conditions. These throughout the lamina propria in affected mutant mice
Immunity
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Figure 4. Aberrant Capping in WASP2/ T, but not B, Lymphocytes
(A±D) T cell capping. Wild-type (A and B) and WASP2/ (C and D) T cells were stimulated in the absence (A and C) or presence (B and D) of
anti-CD3e antibodies followed by immunostaining with FITC-conjugated anti-CD3e antibodies. Caps were readily apparent in most wild-type
cells stimulated through the antigen receptor. Significantly fewer caps were seen in similarly treated WASP2/ T cells (,20% of wild-type) (D).
(E±H) B cell capping. Wild-type (E and F) and WASP2/ (G and H) B cells were stimulated in the absence (E and G) or presence (F and H) of
anti-IgM antibodies followed by immunostaining with FITC-conjugated anti-IgM antibodies. Equivalent rates of antigen receptor±induced
capping were seen in wild-type (F) and WASP2/ (H) B cells.
(compare Figures 7C and 7D). There was a similar in- Discussion
crease in CD81 T cells in affected mice, but no increase
in B2201 B cells (data not shown). Comparison of the WASP-Deficient Phenotype
in Mouse and Humans
In humans, the typical features of WAS are severe immu-
nodeficiency (manifested as recurrent infections) plus ec-
zema and decreased platelet size and numbers (throm-
bocytopenia). These features are usually associated with
decreased numbers of blood lymphocytes (lymphope-
nia), lymphoreticular malignancies, defective T cell func-
tion, and poor immune responses to most protein anti-
gens and all carbohydrate antigens (Remold-O'Donnell
et al., 1996). Young WASP-deficient mice share many
common features with WASP-deficient humans. In par-
ticular, they show mild thrombocytopenia and lympho-
penia as well as defective T cell activation. However,
none of the WASP-deficient mice analyzed have devel-
oped eczema or hematopoeitic malignancies. Likewise,
their antibody responses to a TD antigen and a TI-II
antigen appeared relatively normal. However, as the
WASP-deficient animals have been maintained in a spe-
cific pathogen-free environment, it is not possible to
fully assess their immunocompetence at this time; im-
munizations with other antigens or variations in the im-Figure 5. Normal Serum Immunoglobulin Levels in Wild-Type and
munization protocol may show defects. In addition, itWASP2/ Mice
is possible that other missing aspects of the humanSerum immunoglobulin levels of specific isotypes were determined
phenotype might appear in older mice.by ELISA in 6±8-week-old wild-type (filled circles) and WASP-defi-
cient mice (open circles, six mice in each group). A striking difference between the human and murine
Signaling Defects in WASP-Deficient Mice
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Figure 6. Immune Responses to TD and TI-II Antigens Are Similar
between WASP2/ and Wild-Type Mice
(A) Secondary antibody responses to TD antigen TNP-Ova. Second-
ary immune responses of wild-type and WASP-deficient mice were
measured at 21 days, after primary footpad (day 1) and secondary
subcutaneous (day 14) immunizations with 100 mg of TNP-Ova in
incomplete Freund's adjuvant. A control wild-type littermate was
similarly immunized with TNP-Ova in PBS. As above, total TNP-Ig
was determined using serial dilutions of serum by ELISA with TNP-
BSA as capture reagent.
(B) Antibody responses to TI-II antigen TNP-Dextran. Similar anti- Figure 7. WASP2/ Mice Develop Chronic Colitis
body responses were detected in wild-type (WT) and WASP-defi- (A and B) Hematoxylin and eosin staining of colonic tissue from a
cient (WASP2/) mice 10 days following 50 mg intraperitoneal TNP- wild-type (A) and WASP2/ (B) mouse. The mucosa from affected
Dextran immunization. A sham-immunized wild-type littermate was WASP-deficient colons (B) was thickened with crypt hyperplasia
used as control (CONT). Serum dilutions of serum were analyzed and a lymphocytic and neutrophilic infiltrate in the lamina propria.
for TNP-specific total immunoglobulin by ELISA. Results are ex- Crypt abscesses were also present (arrow).
pressed as OD405 of anti-k-specific ELISA using TNP-BSA as cap- (C and D) Immunohistochemical analysis of colonic tissue from a
ture reagent. wild-type (C) and WASP2/ (D) mouse. CD41 T cells were observed
in the lymphocytic infiltrate in WASP2/ mice (D). These cells are
largely absent from wild-type colons (C). Magnification 5 103.
WASP-deficient phenotype is the consistent develop-
ment of chronic colitis in WASP-deficient mice. Although
observed in the WASP-deficient mice may be associ-bloody diarrhea is a feature of WAS in humans, inflam-
ated with their altered T cell function, although furthermatory bowel disease has been reported only once in
analyses will be necessary to resolve this issue.a WAS patient (Hsieh et al., 1988). Chronic colitis com-
monly develops in mice with mutations or other manipu-
lations that alter T cell function or the ratio of T cell WASP Deficiency Affects Antigen Receptor±Induced
Responses in T Cells, but Not B Cellssubsets (Kuhn et al., 1993; Mombaerts et al., 1993; Sadd-
lack et al., 1993; Willerford et al., 1995; reviewed by T cells from human WAS patients have diminished re-
sponses to antigen receptor stimulation and defects inMorales et al., 1996). Therefore, it is likely that the colitis
Immunity
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their actin cytoskeleton (Molina et al., 1993). However, et al., 1998). Moreover, recent studies indicated that
assembly of the actin cytoskeleton and capping maythe results with human WASP-deficient B cells have not
been so clear, with some reports suggesting normal and have a direct role in mediating signals from the TCR and
further suggested that the proliferation defects in Vav-others abnormal antigen receptor signaling (Simon et
al., 1992; Henriquez et al., 1994). Our studies clearly deficient T cells may result from impairment of these
processes (Fischer et al., 1998; Holsinger et al., 1998).demonstrate that, as in humans, T lymphocytes from
WASP-deficient mice have major defects in antigen re- The close correlation between defects in proliferation
and capping in WASP-deficient T versus B cells alsoceptor±induced proliferation; our preliminary studies
suggest that this is, at least in part, due to reduced suggests that these two processes may be directly re-
lated. Therefore, by analogy to the model for defects inprogression through the cell cycle (S. B. S., unpublished
data). In parallel, WASP-deficient T cells are markedly Vav-deficient T cells (Fischer et al., 1998; Holsinger et
al., 1998), the proliferation defects of WASP-deficient Tdefective in their ability to form antigen receptor caps
following anti-CD3e stimulation, a process known to re- cells may result from a defect in activation of a down-
stream signaling pathway dependent on the cappingquire actin polymerization (de Petris, 1974; Kammer et
al., 1983). In contrast, WASP-deficient B cells prolifer- process. On the other hand, the proliferation defect may
reflect an indirect role for WASP in T cell signaling. Forated normally in response to antigen receptor±induced
stimulation, indicating that at least in mice, WASP is not example, altered cell shapes may prevent efficient con-
tact in vitro between WASP-deficient T cells and immo-required for antigen receptor±induced proliferation in B
cells. Likewise, B cell capping was normal in WASP- bilized anti-CD3e antibodies.
Our results clearly demonstrate that WASP is criticaldeficient mice. Together, our studies suggest that there
may be different requirements for WASP in antigen re- for the readout of TCR-mediated signals that lead to
proliferative responses. In this regard, the ability of anti-ceptor signaling in B and T cells. In this context, one
possibility is that the requirement(s) for cytoskeletal re- CD28 costimulation of WASP-deficient T cells to im-
prove TCR-mediated proliferative responses indicatesorganization in antigen receptor signaling in T and B
cells may be different. Alternatively, there may be func- that such costimulatory signals somehow circumvent
this block in TCR-mediated signaling. In addition, thetional redundancy in WASP-deficient B cells, perhaps
mediated by a WASP-like protein such as N-WASP. apparently normal in vivo responses of WASP-deficient
mice to a protein antigen may reflect the fact that in vivo
T-dependent immune responses occur in the context of
Potential Functions for WASP in Mediating costimulatory pathways.Finally, because T cell develop-
TCR Responses ment in the thymus also requires signaling through the
Potential insight into WASP-function may come from CD3 complex and appears normal in WASP-deficient
studies of Vav, a hematopoietic cell-specific Rho family mice, signaling events in these earlier stage cells may
GDP-GTP exchange factor that like WASP has also been occur despite WASP deficiencyÐfor example, because
shown to influence CDC42-mediated effects on the actin of lower thresholds for activation or because of the pres-
cytoskeleton in vivo (Olson et al., 1996). Targeted inacti- ence of redundant factors.
vation of Vav in lymphocytes results in a number of
phenotypic similarities to WASP deficiency, including Experimental Procedures
defective T cell proliferative responses and defective
Targeted InactivationTCR capping following TCR/CD3 stimulation (Fischer et
We cloned the murine homolog of the human WASP gene from aal., 1995; Tarakhovsky et al., 1995; Zhang et al., 1995;
thymus B6/CBA F1 cDNA phage library (Stratagene, La Jolla, CA)Fischer et al., 1998; Holsinger et al., 1998). To date,
using a human WASP cDNA (p427) as probe (Kwan et al., 1995b).
capping studies of Vav-deficient B cells have not been The largest clone contained a 2048 bp insert that encoded an ORF
reported. Also, as in WASP deficiency, B cell develop- of 520 amino acids. Our sequence was virtually identical to that
published except for two amino acid (compared with the publishedment, peripheral B cell numbers, and Ig isotypes are
sequence, our sequence had a glycine replacing an alanine at posi-normal in the context of Vav deficiency (Fischer et al.,
tion 73 and an alanine replacing a valine at position 249) (Derry et1995; Tarakhovsky et al., 1995; Zhang et al., 1995).
al., 1995b). In contrast to the published sequence, all of our clonesHowever, there are significant differences in the two
had poly(A) tails. To isolate WASP genomic sequences, a murine
phenotypes, including a quantitative impairment in T 129Sv l phage genomic library was screened with the mouse WASP
cell development, lack of B1 cells, and impaired B cell cDNA as probe. Several genomic clones were isolated and mapped
by standard techniques. Two phage clones (numbers 3 and 8) con-receptor±induced proliferative responses of B cells in
tained approximately 15 kb of genomic sequence encompassing thethe context of Vav deficiency. Overall, the shared as-
entire WASP coding sequence and included over 1.5 kb upstream ofpects of the Vav-deficient and WASP-deficient pheno-
the translational start site. A 7.5 kb genomic fragment from phagetypes are consistent with the possibility that Vav and
clone 8 spanning exons 1±11 (Derry et al., 1995b) contained within
WASP may be common members of a signal transduc- a NotI±XhoI fragment was subcloned into pBluescript (Stratagene).
tion pathway that regulates proliferation and capping A targeting construct was developed with this plasmid by inserting
a neomycin-resistance (neor) gene into a unique restriction siteupon antigen receptor activation. If so, differences in
within the coding sequence of exon 7 (EcoRV) and a thymidinethe two phenotypes might be attributed to redundant
kinase (tk) gene at the 39 end of the genomic sequence (within anfactors for WASP but not Vav in B cells and early T cells.
XhoI site).TCR activation has been directly linked to actin poly-
TC-1 ES cells (Deng et al., 1996) were electroporated with the
merization and cytoskeletal changes (Melamed et al., targeting construct (pSBS55) and transfectants isolated after posi-
1991; Pardi et al., 1992; Parsey and Lewis, 1993; Phatak tive and negative selection following standard methodology (Man-
sour et al., 1988). To identify ES clones that contained targetedand Packman, 1994; Selliah et al., 1995; Lowin-Kropf
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recombination events within the WASP gene, DNA from transfec- Histological Examination
Specimens were fixed in 10% buffered formalin and stained withtants was screened by Southern blotting procedures with a probe
lying just outside of the targeted region. Targeted ES cells were hematoxylin and eosin. The severity of colitis (grade, 0±3) was deter-
mined according to the diagnostic criteria previously describedused to inject C57BL/6 blastocysts; highly chimeric male mice were
bred to C57BL/6 or 129Sv female mice to generate F1 offspring. (Mombaerts et al., 1993; Mizoguchi et al., 1997). Of mice greater
than four months, 0/8 wild-type mice (0%) had evidence of disease,Female WASP2/1 offspring were bred to 129 wild-type male mice;
50% of male F2 mice were WASP2/. Mating of WASP2/ males with whereas 6/8 WASP-deficient mice (75%) had colitis.
WASP1/2 females yielded WASP2/2 female mice at the expected
frequency. While most of our analyses were performed with WASP2/ Immunohistochemical Analysis
male mice, analyses of a limited number of WASP2/2 female mice Specimens were embedded in OCT (optimal cutting temperature)
gave similar results. For some analyses (i.e., lymphocyte develop- compound (Miles Inc., Elkhart, IN) on dry ice. Sections (4 mm) of
ment, antigen receptor activation, and capping), we also employed specimens were stained by an avidin±biotin complex method as
WASP2/ T or B cells derived from chimeric mice generated by in- described previously (Mombaerts et al., 1993).
jecting WASP2/ ES cells into RAG2-deficient blastocysts (RAG2-
deficient blastocyst complementation; Chen et al., 1993). We found Proliferation Analyses
no differences in the analyses of WASP lymphocytes derived from T cells were purified from lymph nodes of WASP-deficient male
either chimeric or germline WASP2/ mice. mice (either WASP2/ germline mice or WASP2//RAG22/2 lymphoid
chimeras) or age-matched wild-type control mice by magnetic sort-
ing and removal of B cells with anti-Ig-coated Dynabeads (Dynal)
Peripheral Blood and Lymphoid Tissue Analyses
using standard procedures. The purity of the resulting population
Platelet and leukocyte counts and redblood cell content were deter-
exceeded 95% as confirmed by FACS analysis. Stimulating antibod-
mined from fresh blood samples of 14 wild-type and 19 WASP2/
ies (PharMingen) were allowed to bind to 96-well tissue culture
mice by measurement on a Coulter counter. Total lymphocyte and
plates at 378C for 60 min (anti-CD3e, 12 mg/ml; anti-CD28, 10 mg/
neutrophil counts were determined by multiplying the leukocyte
ml). Cells (5 3 104) were added to each well and cultured at 378C
counts of individual mice by the percentages of each cell type deter-
in RPMI 1640 medium supplemented with 15% fetal calf serum, 100
mined by counting individual Wright-stained smears. Thymus,
U ml21 penicillin/streptomycin, and 50 mM 2-mercaptoethanol. Con
spleen, and lymph node cell counts were determined from wild-
A (Sigma) and IL-2 (PharMingen) were added to indicated cultures
type and WASP2/ mice with a hemocytometer after collecting organs
at concentrations of 5 mg/ml and 5 ng/ml, respectively. Signaling
and making single-cell suspensions. Splenocytes were counted fol-
pathways bypassing the surface were assessed by stimulation with
lowing red blood lysis. Each set of lymph nodes included axillary,
PMA (10 ng/ml) and ionomycin (0.5 mM). Equivalent results were
femoral, and submandibular lymph nodes. In several mice, FACS
obtained with mutant lymphocytes obtained from either germline
analysis confirmed similar percentages of B and T cells in wild-type WASP2/ mice or WASP2//RAG22/2 lymphoid chimeras. B cell prolifer-
and mutant spleen and lymph node. ations were performed in an identical fashion. Splenic B cells were
purified by isolating B2201 cells from WASP-deficient male mice
(either WASP2/ germline mice or WASP2//RAG22/2 lymphoid chime-FACS Analyses
ras) or age-matched wild-type control mice using flow cytometry.Single-cell suspensions of lymphoid cells were prepared and
The purity of the resulting population exceeded 95% as confirmedstained with antibodies following standard procedures. Antibodies
by FACS analysis. B cells were cultured in media alone or in theused were either phycoerythrin (PE)-, fluorescein (FITC)-, or Cy-
presence of stimulatory anti-IgM (soluble, 4 mg/ml; Southern Bio-Chrome-conjugates from PharMingen (San Diego, CA) and are la-
technology), anti-CD40 (5 mg/ml; PharMingen), or lipopolysaccha-beled on the axis and discussed in the text.
ride (10 mg/ml; Sigma). Each stimulation was performed in the pres-
ence of exogenous IL-4 (2 ng/ml, PharMingen). In each proliferation
Mice and Health Status experiment, wild-type (WASP1/) and WASP2/ T or B cells were cul-
Mice were housed in the animal facility at Children's Hospital under tured for 48 hr, pulsed with 1 mCi [3H]thymidine for an additional 16
specific pathogen-free conditions. Wild-type and WASP-deficient hr, and then collected and scintillation counted.
mice were tested at Charles River Laboratories (Wilmington, MA)
for serology, parasitology, and bacteriology as described previously Capping
(Mombaerts et al., 1993). No potential infectious pathogens known Purified lymph node T cells were incubated at 378C for 20 min in
to cause colitis were found in our animal facility except for Helico- the absence or presence of both soluble (10 mg/ml) and plate-bound
bacter spp., which were found in both wild-type and mutant mice. (10 mg/ml) anti-CD3e antibodies (PharMingen), collected and cyto-
Some Helicobacter species have been associated with colitis in spun onto poly-L-lysine coated glass slides, fixed in 3.7% form-
immunodeficient mice (Shomer et al., 1997; Ward et al., 1997). aldehyde, permeabilized with 0.1% Triton X, stained with FITC-
conjugated anti-CD3e (PharMingen), coverslips applied, and then
immediately analyzed and photographed at 1003 using a ZeissImmunizations
fluorescent microscope. B cell capping experiments were per-To measure TI-II immune responses, wild-type and WASP2/ mice
formed with splenic B cells analogous to Tcell capping experiments,were immunized intraperitoneally with 50 mg of TNP-Dextran in PBS.
except stimulating antibodies were anti-IgM (Southern Biotechnol-Serum was analyzed at day 10 for TNP-specific total immunoglobu-
ogy) and staining antibodies were FITC-conjugated anti-IgM (Phar-lin by ELISA. To measure TD immune responses, wild-type and
Mingen). The rate of capping of unstimulated and stimulated wild-WASP2/ mice were immunized in the footpad with 100 mg of TNP-
type and WASP2/ B and T cells was determined by three separateOva in incomplete Freund's adjuvant on day 1 and boosted subcuta-
investigators (blinded to antibody stimulation and to cell type) whoneously with 100 mg of TNP-Ova on day 14. Specific secondary anti-
counted the number of caps in approximately 200 cells per exper-TNP total immunoglobulin responses were determined from serum
iment.on day 21 by ELISA.
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